State Street Corp Neogenomics Inc Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Neogenomics Inc stock. As of the latest transaction made, State Street Corp holds 5,198,487 shares of NEO stock, worth $57.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,198,487

Previous 4,958,582 4.84%

Holding current value

$57.7 Million

Previous $73.1 Million 17.13%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $3.12 Million - $4.42 Million	239,905 Added 4.84%	5,198,487 $85.7 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $1.08 Million - $1.43 Million	80,449 Added 1.65%	4,958,582 $73.1 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $255,425 - $309,612	-19,633 Reduced 0.4%	4,878,133 $67.7 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $742,663 - $886,864	52,821 Added 1.09%	4,897,766 $77 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $928,278 - $1.65 Million	-79,544 Reduced 1.62%	4,844,945 $78.4 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $23,121 - $33,968	-1,903 Reduced 0.04%	4,924,489 $60.6 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $567,130 - $797,602	40,222 Added 0.82%	4,926,392 $79.2 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $2.15 Million - $4.59 Million	236,236 Added 5.08%	4,886,170 $85.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $2.79 Million - $5.22 Million	432,774 Added 10.26%	4,649,934 $43 Million
Q3 2022 Nov 15, 2022	BUY	$7.86 - $12.91 $918,063 - $1.51 Million	116,802 Added 2.85%	4,217,160 $36.3 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $996,836 - $1.97 Million	141,195 Added 3.57%	4,100,358 $33.4 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $1.83 Million - $5.31 Million	150,466 Added 3.95%	3,959,163 $48.1 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $6.95 Million - $11.1 Million	227,955 Added 6.37%	3,808,697 $130 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $3.8 Million - $4.79 Million	91,271 Added 2.62%	3,580,742 $173 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $6.96 Million - $9.83 Million	190,095 Added 5.76%	3,489,471 $158 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $5.96 Million - $8.59 Million	143,480 Added 4.55%	3,299,376 $159 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $681,262 - $1.07 Million	18,882 Added 0.6%	3,155,896 $170 Million
Q3 2020 Nov 10, 2020	SELL	$33.26 - $40.48 $2.48 Million - $3.02 Million	-74,679 Reduced 2.33%	3,137,014 $116 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $4.94 Million - $6.33 Million	204,087 Added 6.79%	3,211,693 $99.5 Million
Q1 2020 May 11, 2020	BUY	$20.5 - $34.53 $61.7 Million - $104 Million	3,007,606 New	3,007,606 $83 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Neogenomics Inc Transaction History